Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease

Infection and Immunity

Volumn 64, Issue 11, 1996, Pages 4744-4750

  Burns Jr , Eugene H ^a   Marciel, Ann Marie ^a   Musser, James M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; BACTERIAL ENZYME; COLLAGEN TYPE 4; COLLAGENASE; CYSTEINE PROTEINASE; GELATINASE; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR;

ARTICLE; CYTOPATHOGENIC EFFECT; DOSE TIME EFFECT RELATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

EID: 10244261522     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.11.4744-4750.1996     Document Type: Article

References (50)

1. Abolnik, I. Z., and D. J. Sexton. 1994. Necrotizing fasciitis and myositis caused by group A streptococci: epidemiology, diagnosis, and treatment of "flesh-eating bacteria." N. C. Med. J. 55:464-466.
2. Agarwal, B. L. 1981. Rheumatic heart disease unabated in developing countries. Lancet ii:910-911.
3. Alexander, C. M., and Z. Werb. 1991. Extracellular matrix degradation, p. 255-302. In E. D. Hay (ed.), Cell biology of extracellular matrix, 2nd ed. Plenum Press, New York.
4. Baramova, E., and J.-M. Foidart. 1995. Matrix metalloproteinase family. Cell Biol. Int. 19:239-242.
5. Belani, K., P. M. Schlievert, E. L. Kaplan, and P. Ferrieri. 1991. Association of exotoxin-producing group A streptococci and severe disease in children. Pediatr. Infect. Dis. J. 10:351-354.
6. Birkedal-Hansen, H. 1993. Role of cytokines and inflammatory mediators in tissue destruction. J. Periodontal Res. 28:500-510.
7. Braunhut, S. J., and M. A. Moses. 1994. Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metallo-proteinases (TIMP). J. Biol. Chem. 269:13472-13479.
8. Burns, E. H., Jr., A. M. Marciel, and J. M. Musser. Unpublished data.
9. Carey, D. J. 1991. Control of growth and differentiation of vascular cells by extracellular matrix proteins. Annu. Rev. Physiol. 53:161-177.
10. Chang, J. C., A. Wysocki, K.-M. Tchou-Wong, N. Moskowilz, V. Zhang, and W. N. Rom. 1996. Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteases. Thorax 51:306-311.
11. Congeni, B. L. 1992. The resurgence of acute rheumatic fever in the United States. Pediatr. Ann. 21:816-820.
12. Cornelius, L. A., L. C. Nehring, J. D. Roby, W. C. Parks, and H. G. Welgus. 1995. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. J. Invest. Dermatol. 105:170-176.
13. Ferrieri, P., and E. L. Kaplan. 1992. Invasive group A streptococcal infections. Infect. Dis. Clin. N. Am. 6:149-161.
14. Fisher, C., S. Gilbertson-Beadling, E. A. Powers, G. Petzold, K. Poorman, and M. A. Mitchell. 1994. Interstitial collagenase is required for angiogenesis in vitro. Dev. Biol. 162:499-510.
15. Gearing, A. J. H., P. Beckett, M. Christodoulou, M. Churchill, J. Clements, A. H. Davidson, A. H. Drummond, W. A. Galloway, R. Gilbert, J. L. Gordon, T. M. Leber, M. Mangan, K. Miller, P. Nayee, K. Owen, S. Patel, W. Thomas, G. Wells, L. M. Wood, and K. Woolley. 1994. Processing of tumour necrosis factor-α precursor by mectalloproteinases. Nature (London) 370:555-557.
16. Gerlach, D., H. Knoll, W. Kohler, J. H. Ozegowski, and V. Hribalova. 1983. Isolation and characterization of erythrogenic toxins. V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor. Zentralbl. Bakteriol. Hyg. Abt. 1 Orig. A 255:221-233.
17. Golub, L. M., M. Wolff, S. Roberts, H.-M. Lee, M. Leung, and G. S. Payonk. 1994. Treating periodontal diseases by blocking tissue-destructive enzymes. J. Am. Dent. Assoc. 125:163-171.
18. Gubba, S., and J. M. Musser. Unpublished data.
19. Hanemaaijer, R., P. Koolwijk, L. le Clereq, W. J. A. de Vree, and V. W. M. van Hinsbergh. 1993. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Biochem. J. 296:803-809.
20. Hauser, A. R., and P. M. Schlievert. 1990. Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor. J. Bacteriol. 172:4536-4542.
21. Holm, S. E., A. Norrby, A. M. Bergholm, and M. Norgren. 1992. Aspects of pathogenesis of serious group A streptococcal infections in Sweden. 1988-1989. J. Infect. Dis. 166:31-37.
22. Jevon, G. P., W. M. Dunne, Jr., H. K. Hawkins, D. L. Armstrong, and J. M. Musser. 1994. Fatal group A streptococcal meningitis and toxic shock-like syndrome: case report. Clin. Infect. Dis. 18:91-93.
23. Kapur, V., J. T. Maffei, R. S. Greer, L.-L. Li, G. J. Adams, and J. M. Musser. 1994. Vaccination with streptococcal extracellular cysteine proteasc (interleukin-1β convertase) protects mice against challenge with heterologous group A streptococci. Micron. Pathog. 16:443-450.
24. Kapur, V., M. W. Majesky, L.-L. Li, R. A. Black, and J. M. Musser. 1993. Cleavage of interleukin 1β (IL-1β) precursor to produce active IL-1β by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc. Natl. Acad. Sci. USA 90:7676-7680.
25. Kapur, V., S. Topouzis, M. W. Majesky, L.-L. Li, M. R. Hamrick, R. J. Hamill, J. M. Patti, and J. M. Musser. 1993. A conserved Streptococcus pyogenes extracellular cysteine proteasc cleaves human fibronectin and degrades vitronectin. Micron. Pathog. 15:327-346.
26. Kato, S., Y. Sasaguri, S. Azagami, R. Nakano, T. Hamada, N. Arima, A. Tanimoto, and M. Morimatsu. 1994. Ambient pressure stimulates immortalized human aorcic endothelial cells to increase DNA synthesis and matrix metalloproteinase 1 (tissue collagenase) production. Virchows Arch. 425: 385-390.
27. Kato, Y., Y. Nakayama, M. Umeda, and K. Miyazaki. 1992. Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. J. Biol. Chem. 267:11424-11430.
28. Kirschner, S. E., and S. S. Twining. 1993. The effect of Pseudomonas aeruginosa exoproducts on corneal proteases. Invest. Opthalmol. Visual Sci. 34: 2699-2712.
29. Kleiner, D. E., Jr., and W. G. Stetler-Stevenson. 1993. Structural biochemistry and activation of matrix metalloproteases. Curr. Opin. Cell Biol. 5:891-897.
30. Kleiner, D. E., Jr., and W. G. Stetler-Stevenson. 1994. Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 218: 325-329.
31. Koolwijk, P., A. M. Miltenburg, M. G. van Ertk, M. Oudshoorn, M. J. Niedbala, F. C. Breedveld, and V. W. van Hinsbergh. 1995. Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis: correlation with clinical and experimental variables of inflammation. J. Rheumatol. 22:385-393.
32. Kubota, Y., H. K. Kleinman, G. R. Martin, and T. J. Lawley. 1988. Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J. Cell Biol. 107:1589-1598.
33. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bactcriophage T4. Nature (London) 277:680-685.
34. Mackay, A. R., M. Ballin, M. D. Pelina, A. R. Farina, A. M. Nason, J. L. Hartzler, and U. P. Thorgeirsson. 1992. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis 12:168-184.
35. Madri, J. A., L. Bell, M. Marx, J. R. Merwin, C. Basson, and C. Prinz. 1991. Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: models of de-endothelialization and repair. J. Cell. Biochem. 45:123-130.
36. Matsumoto, K., N. B. Shams, L. A. Hanninen, and K. R. Kenyon. 1992. Proteolytic activation of corneal matrix metalloproteinase by Pseudomonas aeruginosa elastase. Curr. Eye Res. 11:1105-1109.
37. Matsumoto, K., N. B. Shams, L. A. Hanninen, and K. R. Kenyon. 1993. Cleavage and activation of corneal matrix metalloproteases by Pseudomonas aeruginosa proteases. Invest. Opthalmol. Visual Sci. 34:1945-1953.
38. Murphy, G., F. Willenbrock, T. Crabbe, M. O'Shea, R. Ward, S. Atkinson, J. O'Connell, and A. Docherty. 1994. Regulation of matrix metalloproteinase activity. Ann. N. Y. Acad. Sci. 732:31-41.
39. Musser, J. M. 1996. Streptococcal superantigen, mitogenic factor, and pyrogenic exotoxin B expressed by Streptococcus pyogenes: structure and function, p. 281-310. In D. Y. M. Leung, B. T. Huber, and P. M. Schlievert (ed.). Superantigens: structure, biology, and relevance to human disease. Marcel Decker, New York.
40. Norrby-Teglund, A., K. Pauksens, M. Norgren, and S. E. Holm. 1995. Correlation between serum TNFa and IL6 levels and severity of group A Streptococcal infections. Scand. J. Infect. Dis. 27:125-130.
41. Ray, J. M., and W. G. Stetler-Stevenson. 1994. The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis, and angiogenesis. Eur. Respir. J. 7:2062-2072.
42. Schnaper, H. W., D. S. Grant, W. G. Stetler-Stevenson, R. Fridman, G. D'Orazi, A. N. Murphy, R. E. Bird, M. Hoythya, T. R. Fuerst, and D. L. French. 1993. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell. Physiol. 156:235-246.
43. Shanley, T. P., D. Schrier, V. Kapur, M. Kehoe, J. M. Musser, and P. A. Ward. 1996. Streptococcal cysteine protease augments lung injury induced by products of group A streptococci. Infect. Immun. 54:870-877.
44. Simor, A. E., L. Louie, B. Schwartz, A. McGeer, S. Scriver, the Ontario GAS Study Project, and D. E. Low. 1993. Association of protease activity with group A streptococcal (GAS) necrotizing fasciitis (NF), abstr. 1164, p. 332. In Program and abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
45. Sorsa, T., T. Ingman, K. Suomalainen, M. Haapasalo, Y. T. Konttinen, O. Lindy, H. Saari, and V. J. Ditto. 1992. Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases. Infect. Immun. 60:4491-4495.
46. Springman, E. B., E. I. Angleton, H. Birkedal-Hansen, and H. E. van Wert. 1990. Multiple modes of activation of latent fibroblast collagenase-evidence for the role of a cys-73 active site zinc complex in latency and a cysteine switch mechanism for activation. Proc. Natl. Acad. Sci. USA 87:364-368.
47. Stevens, D. L., A, E. Bryant, S. P. Hackett, A. Chang, G. Peer, S. Kosanke, T. Emerson, and L. Hinshaw. 1996. Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure. J. Infect. Dis. 173:619-626.
48. Tonetti, M. S., K. Freiburghaus, N. P. Lang, and M. Bickel. 1993. Detection of interleukin-8 and matrix metalloproteinase transcripts in healthy and diseased gingival biopsies by RNA/PCR. J. Periodontal Res. 28:511-513.
49. Werb, Z., P. M. Tremble, O. Behrendtsen, E. Crowley, and C. H. Damskey. 1989. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J. Cell Biol. 109:877-889.
50. Yamada, K. M. 1983. Cell surface interactions with extracellular materials. Annu. Rev. Biochem. 52:761-799.